In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
BRISTOL-MYERS SQUIBB TO ACQUIRE ADNEXUS THERAPEUTICS
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Bristol-Myers Squibb Announces Completion of ConvaTec Divestiture
Cubist Pharmaceuticals and Bristol-Myers Squibb extend collaboration for antiinfective drugs
Cerep and Bristol-Myers Squibb sign collaboration agreement
Ambit Biosciences Announces Second Expansion of Collaboration with Bristol-Myers Squibb